Diagnosis and Management of Dysthyroid Optic Neuropathy.

Q3 Medicine

International Ophthalmology Clinics Pub Date : 2023-07-01 DOI:10.1097/IIO.0000000000000452

Yasuhiro Takahashi, Aric Vaidya

引用次数: 0

Abstract

Dysthyroid optic neuropathy (DON) is the most serious manifestation of thyroid eye disease (TED). According to the EUGOGO clinical guidelines, DON is classified as “sight-threatening” TED.1 The incidence of DON ranges from 4% to 8% in all cases of TED.2 Permanent and irreversible vision loss develops in 30% of cases without treatment,3 whereas vision can be rescued after prompt diagnosis and accurate management in most cases. This paper reviews the diagnosis and management of DON.

查看原文本刊更多论文

甲状腺功能障碍视神经病变的诊断和治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Ophthalmology Clinics Medicine-Ophthalmology

CiteScore

1.40

自引率

0.00%

发文量

期刊介绍： International Ophthalmology Clinics is a valuable resource for any medical professional seeking to stay informed and up-to-date regarding developments in this dynamic specialty. Each issue of this quarterly publication presents a comprehensive review of a single topic in a new or changing area of ophthalmology. The timely, tightly focused review articles found in this publication give ophthalmologists the opportunity to benefit from the knowledge of leading experts in this rapidly changing field.